New Nose Treatment Transforms Lives in Hull Hospitals

Thousands of people suffering from constant blocked noses finally have hope thanks to a breakthrough treatment now available at Hull hospitals.

Patients with chronic rhinosinusitis with nasal polyps (a long-term inflammatory condition) are receiving a new injectable therapy called Dupilumab. The condition affects far more than just breathing. It strips away taste and smell, triggers recurring infections, and disrupts sleep and daily activities.

Hull University Teaching Hospitals started offering the treatment shortly after it received NHS approval in February. The timing couldn't be better for patients who previously faced limited options.

"Before we introduced this biologic therapy, patients didn't have access to these drugs," said Helena Cummings, a senior respiratory nurse specialist. "Instead, they had to take oral steroids which don't come without the risk of side effects."

The old approach carried real dangers. Long-term steroid use can weaken bones, raise blood pressure, and increase infection risk. Now patients have a safer alternative.

The new treatment works differently by targeting the underlying disease rather than just masking symptoms. Patients visit Castle Hill Hospital in Cottingham for an initial assessment by specialists. Those who meet the criteria learn to self-administer the injection at home, giving them control over their own care.

The Ripple Effect

Hull's quick adoption of this therapy puts the hospital among England's pioneers in offering this revolutionary medicine. Other NHS organizations are watching closely as early patients report transformative results.

The impact extends beyond physical relief. When people can breathe freely, taste their meals, and sleep through the night, their entire quality of life improves. Relationships strengthen when constant discomfort no longer dominates every interaction. Work productivity rises when brain fog from poor sleep finally lifts.

The treatment represents a broader shift in how medicine approaches chronic conditions. Rather than managing symptoms with medications that carry their own risks, doctors can now address root causes with targeted therapies.

For patients who've endured years of blocked noses and lost senses, each successful treatment creates another voice advocating for access to this therapy nationwide.

One breakthrough medication is giving thousands of people their lives back, one injection at a time.